Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma
Chenhang Yu, Qiang Li, Yu Zhang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy
Heng Dong, Qiang Li, Yu Zhang, et al.
Advanced Science (2023) Vol. 10, Iss. 18
Open Access | Times Cited: 48
Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments
Shalindu Malshan Jayawickrama, Piyumi Madhushani Ranaweera, Roshan Pradeep, et al.
Cancer Reports (2024) Vol. 7, Iss. 3
Open Access | Times Cited: 8
Head and neck cancer: pathogenesis and targeted therapy
Yan Liu, Nannan Zhang, Yi Wen, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 7
Therapeutic Vaccination in Head and Neck Squamous Cell Carcinoma—A Review
K. Devaraja, Sadhna Aggarwal, Manisha Singh
Vaccines (2023) Vol. 11, Iss. 3, pp. 634-634
Open Access | Times Cited: 14
The Concordant Disruption of B7/CD28 Immune Regulators Predicts the Prognosis of Oral Carcinomas
Shi-Rou Chang, Chung‐Hsien Chou, Chung‐Ji Liu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5931-5931
Open Access | Times Cited: 12
PD-L1/PD-1 Expression in the Treatment of Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders: An Overview of Reviews
Huda Moutaz Asmael Al‐Azzawi, Syed Ameer Hamza, Rita Paolini, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 4, pp. 126-126
Open Access
A bibliometric analysis of immune response in oral cancer
Rongrong Zhang, Runying Guo, Yuqi Xin, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
CCNE2 promotes cisplatin resistance and affects prognosis of head and neck squamous cell carcinoma by targeting MNAT1
Ran An, Xiaolin Xu, Yue Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
In situ treatment with a TLR9 agonist virus-like particle to promote immune responses against oral epithelial dysplasia progression
Yan Xu, Alexandra McMillan, Nikesh Gupta, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 6
Open Access
Disulfidptosis features and prognosis in head and neck squamous cell carcinoma patients: unveiling and validating the prognostic signature across cohorts
Hao Xue, Qianyu Sun, Heqing Zhang, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 3
Open Access | Times Cited: 3
Deciphering the role of HPV-mediated metabolic regulation in shaping the tumor microenvironment and its implications for immunotherapy in HNSCC
Xiangjin Gong, Jingwen Xiong, Yu Gong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
The Prognostic Value of Platelet–Lymphocyte Ratio, Neutrophil–Lymphocyte Ratio, and Monocyte–Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma (HNSCC)—A Retrospective Single Center Study and a Literature Review
Camil Ciprian Mireștean, Mihai Cosmin Stan, Roxana Irina Iancu, et al.
Diagnostics (2023) Vol. 13, Iss. 22, pp. 3396-3396
Open Access | Times Cited: 7
Recent advances in patient‐derived tumor organoids for reconstructing TME of head and neck cancer
Lin Chen, Yinyu Chen, Liangyu Ge, et al.
Journal of Oral Pathology and Medicine (2024) Vol. 53, Iss. 4, pp. 238-245
Open Access | Times Cited: 2
Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer
Chun‐Mei Hu, Min Liu, Yutao Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Long-Lasting Complete Remission in a Patient With Metastatic Metaplastic Breast Cancer Treated With Immune Checkpoint Inhibitor and Chemotherapy: A Case Report and a Review of the Literature
Aydah Al‐Awadhi, Safia Alnaqbi, Alia Albawardi
Cureus (2024)
Open Access | Times Cited: 1
Depth-dependent PD-L1 sampling of head and neck squamous cell carcinoma (HNSCC) – implications for PD-1/PD-L1 checkpoint inhibitor immunotherapy
Madhusudan Roy, Jing-Tang Lin, Sohidul Mondal, et al.
Oral Oncology Reports (2024) Vol. 9, pp. 100188-100188
Open Access | Times Cited: 1
The clinical outcome of pembrolizumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a single center, real world study in China
Zongyu Fan, Rong‐Rong Hui, Houyu Ju, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Prognostic model revealing pyroptosis-related signatures in oral squamous cell carcinoma based on bioinformatics analysis
Qi Lu, Zhangui Tang
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Prognostic significance of serum Chemerin and neutrophils levels in patients with oral squamous cell carcinoma
Xiaoyuan Hu, Ning Wang, Fei Gao, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32393-e32393
Open Access | Times Cited: 1
Immunotherapy for HPV negative head and neck squamous cell carcinoma
Binyumeng Jiang, Ahmed Elkashif, Jonathan A. Coulter, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189138-189138
Open Access | Times Cited: 1
Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy
Kamal S. Saini, Sasikala Somara, Heidi Ko, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Emerging functions and applications of exosomes in oral squamous cell carcinoma
Yingchun Qie, Xia Sun, Yongqiang Yang, et al.
Journal of Oral Pathology and Medicine (2023) Vol. 52, Iss. 10, pp. 886-894
Closed Access | Times Cited: 3
A rapid spectroscopic platform in identifying cisplatin resistance in head and neck squamous cell carcinoma
Shu‐Jen Chiang, Po‐Hang Tseng, Mei‐Chun Lin, et al.
(2024), pp. 15-15
Closed Access
Alum-anchored IL-12 combined with cytotoxic chemotherapy and immune checkpoint blockade enhanced antitumor immune responses in head and neck cancer models
Kellsye P. Fabian, Ginette S. Santiago-Sánchez, Michelle R. Padget, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 10, pp. e009712-e009712
Open Access
Comprehensive analysis of the relationship between RNA modification writers and immune microenvironment in head and neck squamous cell carcinoma
Wei Li, Ying Chen, Yao Zhang, et al.
BMC Immunology (2024) Vol. 25, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top